Strategy Integrating Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors for Oligometastatic Non-Small Cell Lung Cancer: A Narrative Review.
The therapeutic approach for oligometastatic non-small cell lung cancer (NSCLC) is rapidly shifting from palliative care to curative-intent strategies. This shift is largely driven by the integration of immune checkpoint inhibitors (ICIs) and stereotactic body radiation therapy (SBRT). SBRT functions biologically as an...